Compounded Sterile Injectable Recalled Due to Lack of Sterility Assurance
Nephron Sterile Compounding Center LLC is recalling 2210 syringes of a three-drug compounded injectable due to lack of assurance of sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product is a sterile injectable where contamination poses significant risk to patient safety; however, no illnesses or injuries have been reported. Under the rubric, this is a 'risk-of-harm product where injury has not yet been reported,' warranting a High severity score.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling 2210 pre-filled syringes of a compounded sterile injectable containing ropivacaine HCl, clonidine HCl, and ketorolac tromethamine. Affected lot numbers are RP2003A and RP2003B, both expiring July 20, 2022. The product was distributed nationwide in the United States.
The recall is being issued due to lack of assurance of sterility of the compounded product. This issue involves the manufacturing process for the injectable medication.
Healthcare facilities and practitioners that received this product should discontinue use of affected lots and contact Nephron Sterile Compounding Center LLC for return and replacement guidance.
The recalled product
- Product
- Ropivacaine HCl 123 mg (2.46 mg/mL), Clonidine HCl 0.04 mg (0.0008 mg/mL), Ketorolac Tromethamine 15 mg (0.3 mg/mL) Injection, 50 mL syringe, packaged in 5 x 50 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable Compounded
- Hazard
- Affected units
- 2,210
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: RP2003A
- Exp. 7/20/2022
- RP2003B
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 37 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Nephron Sterile Compounding Center LLC
See all →- HighSodium Chloride Injection Recalled for Potential Sterility Compromise
FDA (Drugs) · 2025-03-19
- HighNorepinephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighNephron Phenylephrine HCl Injection Recalled for Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighDiltiazem HCl Injectable Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Norepinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2023-03-08
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15